| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 09/17/1992 | CA2103901A1 Insecticidally effective peptides isolatable from diguetia spider venom |
| 09/16/1992 | WO1992016845A1 Receptor-based screening methods for amylin agonists and antagonists |
| 09/16/1992 | WO1992016645A1 PROTEIN PRODUCTION FROM IMMORTAL CELLS GROWN $i(IN VIVO) |
| 09/16/1992 | WO1992016623A2 Receptors for bombesin-like peptides |
| 09/16/1992 | WO1992016219A1 Polypeptides derived from the human immunodeficiency virus endonuclease protein |
| 09/16/1992 | EP0503916A1 Methods for selecting antibody reagents; anti-idiotype antibodies; and aids vaccine formulations |
| 09/16/1992 | EP0503648A1 CD2-Binding domain of lymphocyte function associated antigen 3 |
| 09/16/1992 | EP0503646A1 Monoclonal antibodies recognizing lymphocyte function associated antigen-3 |
| 09/16/1992 | EP0503484A2 Monoclonal antibodies as antidotes |
| 09/16/1992 | EP0503293A1 Specific chicken egg antibody and method for its production |
| 09/16/1992 | EP0503252A2 Recombinant proteins having the immunoreactivity of Hepatitis B virus e antigens (HBeAg), method for their production and their application in immunoassays and as vaccines |
| 09/16/1992 | EP0502928A1 METHODS OF DETECTING COLLAGEN DEGRADATION -i(IN VIVO). |
| 09/16/1992 | EP0502927A1 Dna segment encoding a gene for a receptor related to the epidermal growth factor receptor |
| 09/16/1992 | EP0502892A1 THE HUMAN C3b/C4b RECEPTOR (CR1) |
| 09/16/1992 | EP0245520B1 Monoclonal antibody against glutathione s-transferase and its use in the diagnosis of cancer |
| 09/16/1992 | CA2105306A1 Receptors for bombesin-like peptides |
| 09/16/1992 | CA2104787A1 Protein production from immortal cells grown in vivo |
| 09/16/1992 | CA2082929A1 Receptor-based screening methods for amylin agonists and antagonists |
| 09/15/1992 | WO1992016644A1 Means for in-vitro diagnosis of constituents of cytoplasmic granules and biological applications |
| 09/15/1992 | WO1992016627A1 Recombinant anticoccidial vaccine |
| 09/15/1992 | WO1992016559A1 The trk tyrosine kinase receptor is the physiological receptor for nerve growth factor |
| 09/15/1992 | US5147783 Methods to screen for ovarian cancer and myocardial infarction |
| 09/15/1992 | US5147782 Protease inhibitor, buffer, chelate compound |
| 09/15/1992 | US5147638 Tumor necrosis factor, antibodies, cytokines |
| 09/15/1992 | US5147637 Administering an anti-infective agent and a monoclonal antibody to reduce inflammation caused by meningitis or encephalitis |
| 09/15/1992 | US5147294 Therapeutic method for reducing chronic pain in a living subject |
| 09/15/1992 | CA2106193A1 Means for in vitro diagnosis of constituents of cytoplasmic granules and biological applications |
| 09/15/1992 | CA2106093A1 Recombinant anticoccidial vaccine |
| 09/15/1992 | CA1307486C Hybridoma production |
| 09/15/1992 | CA1307479C Diagnostic methods and systems for quantifying apo ai |
| 09/15/1992 | CA1307478C Methods and compositions for the identification of metastatic human tumors |
| 09/13/1992 | WO1992016646A1 Anti-idiotype antibodies to human melanoma-associated proteoglycan antigen |
| 09/13/1992 | WO1992016622A1 Cd2-binding domain of lymphocyte function associated antigen 3 |
| 09/13/1992 | WO1992016562A1 Humanised antibodies having modified allotypic determinants |
| 09/13/1992 | CA2105980A1 Humanised antibodies having modified allotypic determinants |
| 09/13/1992 | CA2105477A1 Anti-idiotype antibodies to human melanoma-associated proteoglycan antigen |
| 09/12/1992 | WO1992016612A2 Method of inhibiting padgem-mediated interactions using an inhibitor comprising a 2,6 sialic acid component |
| 09/12/1992 | WO1992015698A1 Murine monoclonal antibodies recognizing polymorphic determinants of hla |
| 09/12/1992 | CA2105997A1 Method of inhibiting padgem-mediated interactions using an inhibitor comprising a 2,6 sialic acid component |
| 09/12/1992 | CA2105969A1 Murine monoclonal antibodies recognizing polymorphic determinants of hla |
| 09/10/1992 | CA2062410A1 Recombinant proteins with the immunoreactivity of hepatitis b virus e antigen (hbeag), a process for the preparation thereof and the use thereof in immunoassays and vaccines |
| 09/09/1992 | WO1992015331A1 Lyophilized monoclonal antibody preparation |
| 09/09/1992 | EP0502812A1 Recombinant antibodies specific for a growth factor receptor |
| 09/09/1992 | EP0502595A2 Amide chelates, their metal complexes and their use in diagnosis and therapy |
| 09/09/1992 | EP0502553A2 Peptide fragment from human villin and antibody thereto |
| 09/09/1992 | EP0502448A2 Method of assaying anti-ubiquitin antibody |
| 09/09/1992 | EP0502416A1 Stimulation of growth with anti-idiotypic antibodies raised against an antibody to a growth potentiating polypeptide |
| 09/09/1992 | EP0502160A1 Aids therapy and vaccine |
| 09/09/1992 | EP0502124A1 Peptides and antibodies that inhibit integrin-ligand binding |
| 09/09/1992 | EP0502050A1 A protein purification method. |
| 09/09/1992 | EP0494931A4 Monoclonal antibodies to segments of hiv-1 reverse transcriptase |
| 09/09/1992 | EP0190159B1 $i(IN VITRO) DETECTION OF GASTROINTESTINAL CANCER |
| 09/09/1992 | CA2082169A1 Freeze-dried preparation containing monoclonal antibody |
| 09/08/1992 | US5145790 Immunoassay, fluorescein derivative |
| 09/08/1992 | US5145773 Contact with monoclonal antibodies to form antigen-antibody complex |
| 09/08/1992 | US5145676 Method and agents for promoting wound healing |
| 09/08/1992 | CA2062454A1 Amide-chelates, their metal complexes as well as their use in diagnosis and treatment |
| 09/08/1992 | CA1307218C Onco-fetal specific monoclonal antibodies methods of preparation and use |
| 09/08/1992 | CA1307217C Monoclonal antibodies specific for eikenella corrodens |
| 09/07/1992 | WO1992015683A1 Humanized and chimeric monoclonal antibodies |
| 09/03/1992 | WO1992014843A1 Aptamer specific for biomolecules and method of making |
| 09/03/1992 | WO1992014837A1 Intestinal trefoil proteins |
| 09/03/1992 | WO1992014834A1 Insulin-like growth factor binding protein |
| 09/03/1992 | WO1992014823A1 Mycobacterium polypeptides and nucleic acids encoding them for diagnosis and control of tuberculosis |
| 09/03/1992 | WO1992014815A1 Cultures of permanent lines of human promyelocyte cells, their use for screening molecules useful particularly in treating leukemias |
| 09/03/1992 | WO1992014752A1 Primitive cell colony stimulating factors vectors, antibodies, and methods of use |
| 09/03/1992 | WO1992014750A1 Recombinant thrombin receptor and related pharmaceuticals |
| 09/03/1992 | WO1992014749A1 Thyroid-derived chondrocyte-stimulating factor |
| 09/03/1992 | WO1992014704A1 2-substituted-2-imidazolines |
| 09/03/1992 | WO1992014490A1 Composition and method for immunostimulation in mammals |
| 09/03/1992 | DE4125251C1 Drug containing a bovine protein homologous to human MCP-1 - for treating inflammation, tumours, thrombosis, and immune reactions, also for diagnosis |
| 09/03/1992 | CA2106099A1 Cultures of permanent lines of human promyelocyte cells and their use for screening molecules useful particularly in treating leukemias |
| 09/03/1992 | CA2104698A1 Aptamers specific for biomolecules and methods of making |
| 09/03/1992 | CA2104394A1 Recombinant thrombin receptor and related pharmaceuticals |
| 09/03/1992 | CA2104104A1 Intestinal trefoil proteins |
| 09/03/1992 | CA2081352A1 Composition and method for immunostimulation in mammals |
| 09/02/1992 | EP0501882A2 Method of anti LHRH immunoneutralization of non-castrated male animals and peptide therefore |
| 09/02/1992 | EP0501779A1 Antibodies reactive with human cytosolic phospholipase A2 |
| 09/02/1992 | EP0501445A1 Pharmaceutical composition comprising interleukin-2 |
| 09/02/1992 | EP0501321A1 Immunosuppressive drug containing an anti-estradiol antibody |
| 09/02/1992 | EP0501320A1 Immunopotentiating drug containing an anti-testosterone antibody |
| 09/02/1992 | EP0501233A1 Hybridomas and monoclonal antibodies that inhibit anti-CD3-stimulated T cell proliferation |
| 09/02/1992 | EP0501215A2 Fusion proteins with monoclonal antibody, Linker and beta Glucuronidase for prodrug activation; preparation and use thereof |
| 09/02/1992 | EP0500921A1 Na-k-atpase inhibiting natriuretic substances |
| 09/02/1992 | EP0500826A1 Apo ai polypeptides, antibodies, and immunoassays |
| 09/02/1992 | EP0500785A1 A human t cell reactive feline protein (trfp) isolated from house dust and uses therefor |
| 09/02/1992 | EP0500734A1 Protein complexes having factor viii:c activity and production thereof |
| 09/02/1992 | EP0500685A1 Method to identify analyte-binding ligands |
| 09/02/1992 | EP0493418A4 Method of producing fusion proteins |
| 09/02/1992 | CA2061738A1 Antibodies reactive with human cytosolic phospholipase a2 |
| 09/01/1992 | US5144010 Method of producing monoclonal auto-anti-idiotypic antibodies |
| 09/01/1992 | US5144007 Thyroid hormone receptor |
| 09/01/1992 | US5143901 Preparation for treating and preventing thromboses and thromboembolic complications, use of such a preparation and a method of producing the same |
| 09/01/1992 | US5143854 Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof |
| 09/01/1992 | US5143843 Method for production of monoclonal antibodies for cancer diagnosis and therapy |
| 09/01/1992 | US5143727 Method for preventing diarrhea |
| 09/01/1992 | CA1306964C Method for the preparation of immunoglobulins suitable for intravenous administration |
| 09/01/1992 | CA1306961C Production and characterization of hybridoma antibodies directedspecifically against common determinant(s) present among closely related, but distinct proteins |
| 09/01/1992 | CA1306946C Specific antibody-containing substance from eggs and method of production and use thereof |
| 08/29/1992 | CA2104285A1 Recombinant fiv glycoprotein 160 and p24 gag protein |